ProMIS Neurosciences, Inc.
PMN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | -100% | – |
| Cost of Goods Sold | $0 | $10 | $0 | $6 |
| Gross Profit | $0 | -$10 | $0 | -$6 |
| % Margin | – | – | – | -71,796.9% |
| R&D Expenses | $11 | $8 | $16 | $5 |
| G&A Expenses | $6 | $7 | $7 | $3 |
| SG&A Expenses | $6 | $6 | $7 | $3 |
| Sales & Mktg Exp. | $0 | -$1 | $0 | $0 |
| Other Operating Expenses | $0 | -$6 | $0 | $0 |
| Operating Expenses | $17 | $8 | $23 | $8 |
| Operating Income | -$17 | -$19 | -$23 | -$8 |
| % Margin | – | – | – | -101,363.6% |
| Other Income/Exp. Net | $20 | $1 | $5 | -$1 |
| Pre-Tax Income | $3 | -$18 | -$18 | -$9 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $3 | -$18 | -$18 | -$10 |
| % Margin | – | – | – | -118,662.2% |
| EPS | 2.75 | -35.5 | -42.5 | -41.75 |
| % Growth | 107.7% | 16.5% | -1.8% | – |
| EPS Diluted | 2.75 | -35.5 | -42.5 | -41.75 |
| Weighted Avg Shares Out | 1 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 1 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $3 | -$18 | -$18 | -$9 |
| % Margin | – | – | – | -114,612.9% |